Latest News about ABBV
Recent news which mentions ABBV
From Benzinga
AbbVie's Options: A Look at What the Big Money is Thinking
October 09, 2024
Tickers
ABBV
From Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
From Benzinga
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
October 07, 2024
Tickers
ABBV
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 07, 2024
From Benzinga
3 Magnificent Dividend Stocks to Buy in October
October 06, 2024
From Motley Fool
Tickers
ABBV
From Motley Fool
From Motley Fool
From Benzinga
Comparing AbbVie With Industry Competitors In Biotechnology Industry
October 03, 2024
From Benzinga
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
October 03, 2024
From Benzinga
5 Best Dividend Growth Stocks to Buy in October
October 02, 2024
From Motley Fool
From Benzinga
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
From Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
September 26, 2024
From Benzinga
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
September 26, 2024
From Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
September 26, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
